APEX Ventures logo

APEX Ventures

Europe, Wien, Austria, Vienna

Description

APEX Ventures is a deep-tech and medical-focused venture capital firm.

Investor Profile

APEX Ventures has made 54 investments, with 6 in the past 12 months and 30% as lead.

Stage Focus

  • Seed (63%)
  • Series A (20%)
  • Pre Seed (9%)
  • Series Unknown (6%)
  • Convertible Note (2%)

Country Focus

  • Germany (39%)
  • United Kingdom (24%)
  • Austria (22%)
  • United States (7%)
  • Spain (4%)
  • Switzerland (2%)
  • France (2%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Software
  • Health Care
  • Information Technology
  • Machine Learning
  • Medical
  • Medical Device
  • Health Diagnostics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does APEX Ventures frequently co-invest with?

Nina Capital
Europe, Catalonia, Spain, Barcelona
Co-Investments: 5
11k Ventures
Europe, Hamburg, Germany, Hamburg
Co-Investments: 3
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 5
B&C Innovation Investments
Europe, Wien, Austria, Vienna
Co-Investments: 3
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 4
Amadeus Capital Partners
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 3
University of Cambridge Enterprise
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 4
CG
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 3
Entrepreneur First
Europe, England, United Kingdom, London
Co-Investments: 3
R42 Group
North America, California, United States, Stanford
Co-Investments: 4

Which angels does APEX Ventures often collaborate with?

CK
Europe, Bayern, Germany, München
Shared Deals: 2
MO
Europe, Berlin, Germany, Berlin
Shared Deals: 1
JS
North America, California, United States, Santa Monica
Shared Deals: 1
HH
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 2
CD
North America, California, United States, San Francisco
Shared Deals: 2
IL
Europe, Germany
Shared Deals: 1
IB
Europe, Nordrhein-Westfalen, Germany, Cologne
Shared Deals: 2
AK
Europe, Hamburg, Germany, Hamburg
Shared Deals: 1
CM
North America, California, United States, Beverly Hills
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by APEX Ventures?

Quibim

Valencia, Comunidad Valenciana, Spain

Quibim is a radiomics company specializing in quantitative imaging of biomarkers and medical applications in precision medicine.

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareHealth Diagnostics
Series AJan 28, 2025
Amount Raised: $50,000,000
Robeaute

Paris, Ile-de-France, France

Robeaute is a research and development agency that develops neurosurgical microrobots that can adapt to different types of medical evidence.

MedicalMedical Device
Series AJan 14, 2025
Amount Raised: $28,000,000
HyperHeat

Offenburg, Baden-Wurttemberg, Germany

Climate Tech // Industrial Heat

ManufacturingRenewable Energy
Pre SeedNov 26, 2024
Amount Raised: $3,147,495
GEMESYS

Bochum, Nordrhein-Westfalen, Germany

Next generation AI hardware - a fully analog chip, inspired by the human brain, enabling both training and inference on edge devices.

Artificial Intelligence (AI)HardwareInternet of ThingsSemiconductor
Pre SeedNov 19, 2024
Amount Raised: $9,122,017
TriLite Technologies

Vienna, Wien, Austria

TriLite Technologies is a developing world display tech for AR/VR applications.

ComputerInformation TechnologyTelecommunications
Series ASep 11, 2024
Amount Raised: $22,020,636
CardiaTec Biosciences

Cambridge, Cambridgeshire, United Kingdom

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

Artificial Intelligence (AI)BiotechnologyLife Science
SeedSep 10, 2024
Amount Raised: $6,500,000
Senisca

Exeter, Devon, United Kingdom

Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.

BiotechnologyHealth Care
SeedMar 18, 2024
Amount Raised: $4,708,943
Zetta Genomics

Cambridge, Cambridgeshire, United Kingdom

Zetta Genomics manages large-scale genomic data for precision medicine.

BiotechnologyLife ScienceMedicalPrecision Medicine
SeedFeb 8, 2024
Amount Raised: $2,271,758
Solvemed Limited

Cambridge, Cambridgeshire, United Kingdom

Revolutionizing neurology diagnostics and drug discovery with Artificial Intelligence.

Artificial Intelligence (AI)Machine LearningMedical Device
SeedOct 5, 2023
Amount Raised: $3,899,895
sewts

Garching Bei München, Bayern, Germany

Saas, Robotic, Machine Learning

Machine LearningSoftware
Series AAug 9, 2023
Amount Raised: $7,684,108